1.
Global malaria mortality between 1980 and 2010: a systematic analysis
by Murray, Christopher JL, Prof
The Lancet (British edition), 2012, Vol.379 (9814), p.413-431
2.
Chagas disease
by Rassi, Anis, Dr
The Lancet (British edition), 2010, Vol.375 (9723), p.1388-1402
3.
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
by Witkowski, Benoit, PhD
The Lancet infectious diseases, 2013, Vol.13 (12), p.1043-1049
5.
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
by Phyo, Aung Pyae, MD
The Lancet (British edition), 2012, Vol.379 (9830), p.1960-1966
6.
Shrinking the malaria map: progress and prospects
by Feachem, Richard GA, Prof
The Lancet (British edition), 2010, Vol.376 (9752), p.1566-1578
7.
Changes in the burden of malaria in sub-Saharan Africa
by O'Meara, Wendy Prudhomme, PhD
The Lancet infectious diseases, 2010, Vol.10 (8), p.545-555
8.
Operational strategies to achieve and maintain malaria elimination
by Moonen, Bruno, Dr
The Lancet (British edition), 2010, Vol.376 (9752), p.1592-1603
9.
Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis
by Taylor, Steve M, Dr
The Lancet infectious diseases, 2012, Vol.12 (6), p.457-468
10.
Cutaneous leishmaniasis
by Reithinger, Richard, Dr
The Lancet infectious diseases, 2007, Vol.7 (9), p.581-596
11.
The changing risk of Plasmodium falciparum malaria infection in Africa: 2000–10: a spatial and temporal analysis of transmission intensity
by Noor, Abdisalan M, Dr
The Lancet (British edition), 2014, Vol.383 (9930), p.1739-1747
12.
Global economic burden of Chagas disease: a computational simulation model
by Lee, Bruce Y, Dr
The Lancet infectious diseases, 2013, Vol.13 (4), p.342-348
13.
Key gaps in the knowledge of Plasmodium vivax , a neglected human malaria parasite
by Mueller, Ivo, PhD
The Lancet infectious diseases, 2009, Vol.9 (9), p.555-566
14.
Human African trypanosomiasis
by Brun, Reto, Prof
The Lancet (British edition), 2010, Vol.375 (9709), p.148-159
15.
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
by Halstead, Scott B, Dr
The Lancet infectious diseases, 2010, Vol.10 (10), p.712-722
16.
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
by Dondorp, Arjen M, MD
The Lancet (British edition), 2010, Vol.376 (9753), p.1647-1657
17.
The global distribution of clinical episodes of Plasmodium falciparum malaria
by Snow, Robert W
Nature, 2005, Vol.434 (7030), p.214-217
18.
Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study
by Scott, J Anthony G, Dr
The Lancet (British edition), 2011, Vol.378 (9799), p.1316-1323
19.
Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study
by Trape, Jean-François, Dr
The Lancet infectious diseases, 2011, Vol.11 (12), p.925-932
20.
Comparative genomics of the neglected human malaria parasite Plasmodium vivax
by Sargeant, Tobias J
Nature (London), 2008, Vol.455 (7214), p.757-763
